Pharmacotherapy of cerebral ischemia in cocaine dependence

Drug and Alcohol Dependence

Volumn 49, Issue 2, 1998, Pages 133-144

  Kosten, T R ^a  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Cerebral; Cocaine; Ischemia; Neuropsychological; Pharmacotherapy

Indexed keywords

ACETYLSALICYLIC ACID; AMINO ACID RECEPTOR BLOCKING AGENT; ANTITHROMBOCYTIC AGENT; BUPRENORPHINE; COCAINE; EXCITATORY AMINO ACID; GLUTAMATE RECEPTOR ANTAGONIST; KAPPA OPIATE RECEPTOR AGONIST; LAMOTRIGINE;

ARTICLE; BLEEDING; BRAIN ISCHEMIA; BRAIN PERFUSION; DRUG DEPENDENCE; GASTROINTESTINAL SYMPTOM; HUMAN; IMAGING; NEUROPSYCHOLOGY; NEUROTOXICITY; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL;

ASPIRIN; BRAIN; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; COCAINE; COCAINE-RELATED DISORDERS; COGNITION DISORDERS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GLUTAMIC ACID; HUMANS; INTRACRANIAL EMBOLISM AND THROMBOSIS; MALE; NERVE DEGENERATION; NEUROPSYCHOLOGICAL TESTS; PLATELET AGGREGATION INHIBITORS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0031890480     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(97)00158-0     Document Type: Article

References (120)

1. Abelson H.I., Miller J.D. A decade of trends in cocaine use in the household population. NIDA Res. Monograph. 61:1985;35-49.
2. Allen G.W., Cheung R.T., Cechetto D.F. Neurochemical changes following occlusion of M.C. artery in rats. Neuroscience. 68:1995;1037-1050.
3. Amass L., Nardin R., Mendelson J.H., Teoh S.K., Woods B.T. Quantitative magnetic resonance imaging in heroin and cocaine dependent men: preliminary study. Psychiatry Res. 45(1):1992;15-23.
4. The American Nimodipine Study Group, 1992. Clinical trial of nimodipine in acute ischemic stroke. Stroke 23, 3-8. (Erratum, Stroke 23:615, 1992).
5. Antiplatelet Trialists' Collaboration, 1988. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br. Med. J. 296, 320-331.
6. Antiplatelet Trialists' Collaboration, 1994. Collaborative overview of randomized trials of antiplatelet treatment. Part I. Prevention of death, myocardial function, and stroke by prolonged antiplatelet therapy in various categories of patients. Br. Med. J. 308, 81-106.
7. Ardila A., Rosselli M., Strumwasser S. Neuropsychological deficits in chronic cocaine abusers. Int. J. Neurosci. 57:1991;73-79.
8. Azrin A., Rosselli M., Strumwasser S. Recovery of memory and intelligence following chronic cocaine abuse. Clin. Neuropsychol. 6(3):1992;344.
9. Azrin R.L., Millsaps C., Schneider B., Mittenberg W. Abstinent cocaine abusers' neuropsychological functioning on the SMW-R and WAIS-R (Abstract). Clin. Neuropsychol. 9:1995;289.
10. Baskin D.S., Hosobuchi Y., Loh H.U., Lee N.M. Dynorphin (1-13) improves survival in cats with focal cerebral ischemia. Nature. 312:1984;551-552.
11. Bauer L.O. Motoric signs of CNS dysfunction associated with alcohol and cocaine withdrawal. Psychiatry Res. 47:1993;69-77.
12. Beatty W.W., Katzung V.M., Moreland V.J., Nixon S.J. Neuropsychological performance of recently abstinent alcoholics and cocaine abusers. Drug Alcohol Depend. 37(3):1995;247-253.
13. Benveniste H., Drejer J., Schousboe A., Deimer N.H. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374.
14. Berry J., van Gorp W.G., Herzberg D.S., Hinkin C., Boone K., Steinman L., Wilkins J.N. Neuropsychological deficits in abstinent cocaine abusers: Preliminary findings after 2 weeks of abstinence. Drug Alcohol Depend. 32(3):1993;231-237.
15. 2+ in hippocampal neurons. Neuron. 9(2):1992;285-294.
16. Bliss T.V.P., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
17. Bruhn P., Maage N. Intellectual and neuropsychological functions in young men with heavy and long-term patterns of drug abuse. Am. J. Psychiatry. 132:1975;397-401.
18. Buchan A.M., Li H., Cho S., Pulsinelli W.A. Blockade of the AMPA receptor prevents CAI hippocampal injury following severe but transient forebrain ischemia in adult rats. Neurosci. Lett. 132:1991;255-258.
19. Bullock R., Zauner A., Woodward J., Young H.F. Massive persistent release of excitatory amino acids following human occlusive stroke. Stroke. 26(11):1995;2187-2189.
20. Burch J.W., Stanford N., Majerus P.W. Inhibition of platelet prostaglandin synthetase by oral aspirin. J. Clin. Invest. 61:1978;314.
21. Castillo J., Davalos A., Naveiro J., Noya M. Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke. 27(6):1996;1060-1065.
22. Choi D.W. Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci. Lett. 58:1985;293-297.
23. Choi D.W. Dextrorphan and dextromethorphan attenuate glutamate neurotoxicity. Brain Res. 403:1987;333-336.
24. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
25. 31PMR spectroscopy study. MRM. 35(5):1996;658-663.
26. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-695.
27. Daunais J.B., McGinty J.F. Cocaine binges differentially alter striatal preprodynorphin and zif/268 mRNAs. Brain Res. Mol. Brain Res. 29(2):1995;201-210.
28. Dressler F.A., Malekzadeh S., Roberts W.C. Quantitative analysis of amounts of coronary arterial narrowing in cocaine addicts. Am. J. Cardiol. 65:1990;303-308.
29. Dubinsky J.M., Rothman S.M. Intracellular calcium concentrations during 'chemical hypoxia' and excito-toxic neuronal injury. J. Neurosci. 11:1991;2545-2551.
30. Faden A.I. Dynorphin increases extracellular levels of excitatory amino acids in the brain through a non-opioid mechanism. J. Neurosci. 12(2):1992;425-429.
31. Falkeborn M., Persson I., Terent A., Adami H.O., Lithell H., Bergstrom R. Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden. Arch. Int. Med. 153(10):1993;1201-1209.
32. Fals-Stewart W., Lucente S., Shanahan T., Brown L. The relationship of patients' cognitive status and therapists' ratings of psychological distress among psychoactive substance users in long-term residential treatment. J. Subst. Abuse. 7:1995;205-222.
33. Fields W.E., Lemak N.A., Frankowski R.F., Hardy R.J. Controlled trial of aspirin in cerebral ischemia. Stroke. 8:1977;301.
34. Fields W.E., Lemak N.A., Frankowski R.F., Hardy R.J. Controlled trial of aspirin in cerebral ischemia. Part II. Stroke. 9:1978;309.
35. FitzGerald G.A., Oates J.A., Hawiger J., Maas R.L., Roberts L.J., Lawson J.A., Brash A.R. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J. Clin. Invest. 71:1983;676.
36. Flores E.D., Lange R.A., Cigarroa R.G., Hillis L.D. Effect of cocaine on coronary artery dimensions in atherosclerotic coronary artery disease: Enhanced vasoconstriction at sites of significant stenoses. J. Am. Coll. Cardiol. 16:1990;74-79.
37. Gant J.A., Scrutton M.C. Positive interaction between agonists in the aggregation response of human blood platelets: Interaction between ADP, adrenalin, and vasopressin. Br. J. Haematol. 44:1980;109.
38. Gawin F.H., Ellinwood E.H. Cocaine and other stimulants: Actions, abuse and treatment. New Engl. J. Med. 318(18):1988;1173-1181.
39. Glick S.D., Maisonneuve I.M., Raucci J., Archer S. Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Res. 681(1/2):1995;147-152.
40. Grant I., Adams K.M., Carlin A.S., Rennick P.M., Judd L.L., Schooff K. The collaborative neuropsychological study of poly-drug users. Arch. Gen. Psychiatry. 35:1978;1065-1074.
41. He G.Q., Zhang A., Altura B.T., Altura B.M. Cocaine-induced cerebrovasospasm and its possible mechanism of action. J. Pharmacol. Exp. Ther. 268(3):1994;1532-1539.
42. Hoff A.L., Riordan H., Alpert R., Volkow N. Cognitive function in the chronic cocaine abusers. J. Clin. Exp. Neuropsychol. 13:1991;60.
43. Holman B.L., Carvalo P.A., Mendelson J., Teoh S.K., Nardin R., Hallgring E., Hebben N., Johnson K.A. Brain perfusion is abnormal in cocaine dependent polydrug users: A study using Tc-99m-HMPAO and ASPECT. J. Nucl. Med. 32:1991;1206-1210.
44. Holman B.L., Garada B., Johnson K.A., Mendelson J., Hallgring E., Teoh S.K., Worth J., Navia B.A. A comparison of brain perfusion SPECT in cocaine abuse and AIDS dementia complex. J. Nucl. Med. 33(7):1992;1312-1315.
45. Holman B.L., Mendelson J., Garada B., Teoh S.K., Hallgring E., Johnson K.A., Mello N.K. Regional cerebral blood flow improves with treatment in chronic cocaine polydrug users. J. Nucl. Med. 34:1993;723-727.
46. Hurd Y.L., Brown E.E., Finlay J.M., Fibiger H.C., Gerfen C.R. Cocaine self-administration differentially alters mRNA expression of striatal peptides. Brain Res. Mol. Brain Res. 13(1/2):1992;165-170.
47. Juni J.E. Taking brain SPECT seriously: reflections on recent clinical reports in the journal of nuclear medicine. J. Nucl. Med. 35:1994;1891-1895.
48. Kanthan R., Shuaib A., Griebel R., Miyashita H. Intracerebral human microdialysis: in vivo study of an acute focal ischemic model of the human brain. Stroke. 26(5):1995;870-873.
49. Kaplan K.L., Broekman M.J., Chernoff A., Lesznik G.R., Drillings M. Platelet α-granule proteins: studies on release and subcellular localization. Blood. 53:1979;604.
50. Kaye B.R., Fainstat M. Cerebral vacilitis associates with cocaine abuse. J. Am. Med. Assoc. 258:1990;2104-2106.
51. Kloner R.A., Hale S., Alker K., Rezkalla S. The effects of acute and chronic cocaine use on the heart. Circulation. 85:1992;407-419.
52. Kolodgie F.D., Virmani R., Cornhill J.F., Herderick E.E., Smialek J. Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated coronary vasospasm and thrombosis. J. Am. Coll. Cardiol. 17:1991;1553-1560.
53. Kosten, T.R., Best, S., Seibyl, J.P., Wallace, E., Wisniewski, G., Smith, E.O., Woods, S.W., Rinder, H., submitted. Treatment of cerebral perfusion defects in cocaine abusers with aspirin: A pilot study.
54. Kosten, T.R., Cheeres, C., Palumbo, J., Seibyl, J.P., Price, L.H., Woods, S.W., In press a. Regional cerebral blood flow during acute and chronic abstinence from combined cocaine alcohol abuse. Drug Alco Dep.
55. Kosten, T.R., Marison, R., Wallace, E., in press b. Neuropsychological abnormalities in cocaine abusers: Possible correlates in SPECT neuroimaging NIDA Research Monograph.
56. Kreek M.J. Cocaine, dopamine and the endogenous opioid system. J. Addict. Dis. 15(4):1996;73-96.
57. Kuzmin A.V., Semenova S., Gerrits M.A., Zvartau E.E., Van Ree J.M. Kappa-opioid receptor agonist U50, 488H modulates cocaine and morphine self-administration in drug-naïve rats and mice. Eur. J. Pharmacol. 321(3):1997;265-271.
58. Levin J.M., Holman B.L., Mendelson J.H., Teoh S.K., Garada B., Johnson K.A., Springer S. Gender differences in cerebral perfusion in cocaine abuse: Technetium-99m-HMPAO SPECT study of drug-abusing women. J. Nucl. Med. 35:1994;1902-1909.
59. Levine S.R., Washington J.M., Jefferson M.F., Kiernan S.W., Meon M., Feit H., Welsh K.M. Crack cocaine-associated stroke. Neurology. 37:1987;1849-1853.
60. Levine, S.R., Brust, J.C.M., Futrell, N., Brass, L.M., Blake, D. Fayad, P., Schultz, L.R., Millikan, C.H., Ho, K.L., Welch, K.M., 1991. A comparative study of the cerebrovascular complications of cocaine: Alkaloidal versus hydrochloride-a review. Neurology 41 (8), 1173-1177.
61. Lipton S.A. Calcium channel antagonists in the prevention of neurotoxicity. Adv. Pharmacol. 22:1991;271-297.
62. Lipton, S.A., Rosenberg, P.A., 1994. Excitatory amino acids as a final common pathway for neurologic disorders. In: Epstein, F.H. (Ed.), Mechanisms of Disease 330 (9), 613-622.
63. MacDonald J.F., Miljkovic Z., Pennefather P. Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine. J. Neurophysiol. 58:1987;251-266.
64. Manschreck T.C., Schneyer M.L., Weisstein C.C., Laughery J., Rosenthal J., Celada T., Berner J. Freebase cocaine and memory. Compr. Psychiatry. 31(4):1990;369-375.
65. McCabe R.T., Wasterlain C.G., Kucharczyk N., Sofia R.D., Vogel J.R. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors. J. Pharmacol. Exp. Ther. 264:1993;1248-1252.
66. Melamed, J.I., Bleiberg, J., 1986. Neuropsychological deficits in freebase cocaine abusers after cessation of use. Paper presented at the Annual Meeting of the American Psychiatric Association, Washington, DC.
67. Meldrum B., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11:1990;379-387.
68. Meldrum, B.S., 1994. Lamotrigine: a novel approach. Seizure (Suppl A), 41-45.
69. Mena I., Giombetti R., Cody C.K. Acute cerebral blood flow changes with cocaine intoxication (Abstract). Neurology. 40(1):1990;179.
70. Miller B.L., Mena I., Giombetti R., Villanueva-Meyer J., Djenderedjian A.H. Neuropsychiatric effects of cocaine: SPECT measurements. J. Addict. Dis. 11:1992;47-58.
71. Minor R.L., Scott B.D., Brown D.D., Winniford M.D. Cocaine-induced myocardial infarction in patients with normal coronary arteries. Ann. Int. Med. 115:1991;797-806.
72. Mittenberg W., Motta S. Effects of chronic cocaine abuse on memory and learning. Arch. Clin. Neuropsychol. 8:1993;447.
73. Miyamoto T., Ogino N., Yamamoto S., Hayaishi O. Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J. Biol. Chem. 251:1976;2629.
74. Moghaddam B., Bolinao M.L. Glutamatergic antagonists attenuate ability of dopamine uptake blockers to increase extracellular levels of dopamine: implications for tonic influence of glutamate on dopamine release. Synapse. 18:1994;337-342.
75. Muir K.W., Lees K.R. Clinical experience with excitatory amino acid antagonist drugs. Stroke. 26(3):1995;503-513.
76. Muntaner C., Kumor K.M., Nagoshi C., Jaffe J.H. Effects of nifedipine pretreatment on subjective and cardiovascular responses to intravenous cocaine in humans. Psychopharmacology. 105(1):1991;37-41.
77. Ohki S., Ogino N., Yamamato S., Hayaishi O. Prostaglandin hydroperoxidase, an integral part of prostaglandin endoperoxide synthetase. J. Biol. Chem. 254:1979;829.
78. Olney, J.W., 1978. Neurotoxicity of excitatory amino acids. In: McGeer, E.G., Olney, J.W., McGeer, P.L. (Eds.), Kainic Acid as a Tool in Neurobiology. Raven Press, New York, pp. 95-121.
79. Om A., Warner M., Sabri N., Cecich L., Vetrovec G. Frequency of coronary artery disease and left ventricle dysfunction in cocaine users. Am. J. Cardiol. 69:1992;1549-1552.
80. O'Malley S., Gawin F.H. Abstinence symptomatology and neuropsychiatric impairment in chronic cocaine abuse. NIDA Res. Monograph. 101:1990;179-190.
81. O'Malley S., Adamse M., Heaton R.K., Gawin F.H. Neuropsychological impairment in chronic cocaine abusers. Am. J. Drug Alcohol Abuse. 18(2):1992;131-144.
82. Paganini-Hill A. Estrogen replacement therapy and stroke. Prog. Cardiovasc. Dis. 38(3):1995;223-242.
83. Pascual-Leone A., Dhuna A., Anderson D.C. Cerebral atrophy in habitual cocaine abusers: a planimetric CT study. Neurology. 41(1):1991;34-38.
84. Patrignani P., Filabozzi P., Patrono C. Selective, cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J. Clin. Invest. 69:1982;1366.
85. Pearlson G.D., Jeffery P.J., Harris G.J., Ross C.A., Fischman M.W., Camargo E.E. Correlation of acute cocaine induced changes in local cerebral blood flow with subjective effects. Am. J. Psychiatry. 150:1993;495-497.
86. Pupi, A., DeCristofaro, M.T.R., Bacciottini, L., Antoniucci, D., Formiconi, A.R. Mascalchi, M., Meldolesi, U., 1991. An analysis of the arterial input curve for Te-99m-HMPAO: quantification of rCBF using single-photon emission computed tomography J. Nucl. Med. 32(8), 1501-1506.
87. Rinder C.S., Student L.A., Bonan J.L., Rinder H.M., Smith B.R. Aspirin does not inhibit ADP-induced platelet α-granule release. Blood. 82:1993;505.
88. Rinder H.M., Ault K.A., Jatlow P.I., Kosten T.R., Smith B.R. Platelet α-granule release in cocaine users. Circulation. 90:1994;1162-1167.
89. Roberts L.A., Bauer L.O. Reaction time during cocaine versus alcohol withdrawal: Longitudinal measures of visual and auditory suppression. Psychiatry Res. 46:1993;229-237.
90. Ross R., Glomset J., Kariya B., Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc. Natl. Acad. Sci. USA. 71:1974;1207-1210.
91. Ross R., Vogel A. The platelet-derived growth factor. Cell. 14:1978;203-210.
92. Ross R. The pathogenesis of atherosclerosis-an update. New Engl. J. Med. 314:1986;488-494.
93. Roth G.J., Machuga E.T., Ozols J. Isolation and covalent structure of the aspirin-modified, active-site region of prostaglandin synthetase. Biochemistry. 22:1983;4672-4675.
94. Roth G.J., Machuga E.T., Strittmatter P. The heme-binding properties of prostaglandin synthease from sheep vesicular gland. J. Biol. Chem. 256:1983;10018-10022.
95. Roth G.J., Calverley D.C. Aspirin, platelets, and thrombosis: theory and practice. Blood. 8:1994;885.
96. Rozza A., La Torre G., Scavini C., Lanza E., Favalli L., Racagni G. K-opioid receptor changes in experimental models of cerebral ischaemia and atherosclerosis in the rabbit. Pharmacol. Res. 26(4):1992;409-415.
97. Rylander, G., 1969. Clinical and medico-criminological aspects of addiction to central stimulating drugs. In: Sjoquist, F., Tootie, M. (Eds.), Abuse of Central Stimulants. Almquist and Wiksell, Stockholm, pp. 251-274.
98. Schmidt R., Fazekas F., Reinhart B., Kapeller P., Fazekas G., Offenbacher H., Eber B., Schumacher M., Freidl W. Estrogen replacement therapy in older women: A neuropsychological and brain MRI study. J. Am. Geriatr. Soc. 44(11):1996;1307-1313.
99. Selby M.J., Azrin R.L., Ireland S.J., Moreno J.K. Differential recovery of neuropsychological functioning in alcohol, cocaine, and polysubstance abusers (Abstract). Arch. Clin. Neuropsychol. 10:1995;390.
100. Siffet W., Gengenbach S., Scheid P. Inhibition of platelet aggregation by amiloride. Thromb. Res. 44:1986;235.
101. Silverman D.G., Kosten T.R., Jatlow P.I., Gutter V., Fleming J., O'Connor T.Z., Byck R. Decreased digital flow persists after the abatement of cocaine-induced hemodynamic stimulation. Anesth. Anal. 84:1997;46-50.
102. Smiley P.L., Johnson M., Bush L., Gibb J.W., Hanson G.R. Effects of cocaine on extrapyramidal and limbic dynorphin systems. J. Pharmacol. Exp. Ther. 253(3):1990;938-943.
103. Smith S.E., Meldrum B.S. Cerebroprotective effect of a non-N-methyl-D-asparate antagonist, GYKI 52466, after focal ischemia in the rat. Stroke. 23:1992;861-864.
104. Sorensen P.S., Pedersen H., Petersson H., Heltberg A., Simonsen N., Munck O., Ardersen L.A. Acetylsalicyclic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. a Danish cooperative study. Stroke. 14:1983;55.
105. +-dependent glutamate/asparate transporter from rat brain. Proc. Natl. Acad. Sci. USA. 89:1992;10955-10959.
106. 133Xe rCBF and Tc-99m-HMPAO. J. Nucl. Med. 32 (5), 1021.
107. Strickland T.L., Mena I., Villanueva-Meyer J., Miller B.L., Cummings J., Mehringer C.M., Satz P., Myers H.J. Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J. Neuropsychiatry Clin Psychiatry. 5:1993;419-427.
108. Szatkowski M., Barbour B., Attwell D. Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature. 348:1990;443-446.
109. Trites, R.L., Suh, M., Offord, D., Nieman, G., Preston D., 1974. Neuropsychologic and psychosocial antecedents and chronic effects of prolonged use of solvents and methamphetamine. Paper presented at the Internation Psychiatry Res. Socity, Ottawa, Canada.
110. Tuchman A.J., Daras M., Zalzal P., Mangiardi J. Intracranial hemorrhage after cocaine abuse (letter). J. Am. Med. Assoc. 257:1987;1175.
111. Tumeh S.S., Nagel J.S., English R.J., Moore M., Holman B.L. Cerebral abnormalities in cocaine abusers: demonstration by SPECT perfusion brain scintigraphy. Work in progress. Radiology. 176:1990;821-824.
112. Vitullo J.C., Karam R., Mekhail N., Wicker P., Engelmann G.L., Khairallah P.A. Cocaine-induced small vessel spasm in isolated rat hearts. Am. J. Pathol. 135:1989;85-91.
113. Volkow N.D., Mullani N., Gould L., Adler S., Krajewski K. Cerebral blood flow in chronic cocaine users: a study with positron emission tomography. Br. J. Psychiatry. 152:1988;641-648.
114. Volkow N.D., Hitzemann R., Fowler J.S., Dewey S., Hoff A. Regional brain metabolic activity during different stages of cocaine withdrawal. J. Nucl. Med. 32:1991;960.
115. Volkow, N.D., Fowler, J.S., Wolf, A.P., Hitzemann, R., Dewey, S., Bendriem. B., Alpert, R., Hoff, A., 1991b. Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am. J. Psychiatry 148 (5), 621-626.
116. Wagner J.J., Terman G.W., Chavkin C. Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. Nature. 363:1993;451-454.
117. Wallace E.A., McMahon T., Zubal G., Wisniewski G., van Dyck C.H., Pfau S.E., Rosen M.I., Pearsall H.R., Sullivan M.C., Hoffer P.B., Kosten T.R., Woods S.W. Regional cerebral blood flow effects of acute cocaine infusion. Problems of Drug Dependence 1993. NIDA Research Monograph. 141:1994;325.
118. Washton A.M., Gold M.S., Pottash A.L. Survey of 500 callers to a national cocaine help-line. Psychosomatics. 25:1984;771-775.
119. Weber D.A., Franceschi D., Ivanovic M., Atkins H.L., Cabahug C., Wong C.T., Susskind H. SPECT and planar brain imaging in crack abuse: iodine-123-iodoamphetamine uptake and localization. J. Nucl. Med. 34(6):1993;899-907.
120. Woods S.W., O'Malley S.S., Martini B.L., McDougle C.J., Price L.H., Krystal J.H., Hoffer P.B., Kosten T.R. SPECT regional cerebral blood flow and neuropsychological testing in non-demented HIV-positive drug abusers. Prog. Neuro-psychopharmacol. Biol. Psychiatry. 15:1991;649-662.